PPARA and diabetes mellitus: Mechanistic studies indicate that Cirsiliol exerts its effects by synergistically activating the PPAR-α/AMPK signaling axis, regulating the expression of key fatty acid oxidation molecules CPT1 and p-ACC, restoring mitochondrial membrane potential, and inhibiting the release of pro-inflammatory factors, thereby providing multidimensional intervention for diabetic cardiac injury.